Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

6 Oct 2018

Podcast: KHN’s ‘What the Health?’ Some things old, some things new

Congress passed major health-related legislation in time for the fiscal year, which began Monday, including a broad bill to address the opioid epidemic and a spending bill for the Department of Health and Human Services.

4 Oct 2018

Australia will soon become the first country to eradicate cervical cancer

According to an announcement from the International Papillomavirus Society, Australia could soon become the first country to eradicate cervical cancer.

4 Oct 2018

Presence of high-risk HPV in cervical cancer diagnosis linked to improved prognosis

The presence of the human high-risk papillomavirus in the diagnosis of invasive cervical cancer is linked to a greatly improved prognosis compared with if high-risk HPV cannot be identified in the tumor, researchers at Karolinska Institutet in Sweden report in the scientific journal PLOS Medicine.

3 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

‘Contraception deserts’ likely to widen under new Trump administration policy

When Nikia Jackson needed to be screened for a sexually transmitted disease, she wanted a clinic that was reputable, quick and inexpensive.

28 Sep 2018

New combination therapy shows potential in treating incurable HPV-related cancers

A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology.

28 Sep 2018

HPV vaccination offers best protection against cervical and genital cancers

In low-resource countries without well-developed screening programs, expanding access to human papilloma virus vaccination is the best means of preventing cervical cancer and other diseases caused by HPV infection, according to an editorial in the October special issue of the Journal of Lower Genital Tract Disease, official journal of ASCCP.

28 Sep 2018

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.

27 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

NUS researchers develop new device for quick and accurate screening of diseases

A multidisciplinary team of researchers at the National University of Singapore has developed a portable, easy-to-use device for quick and accurate screening of diseases.

18 Sep 2018

Adding PET scans to CT imaging can change treatment for women with cervical cancer

An Ontario clinical study that shows adding PET imaging to conventional CT imaging to stage locally advanced cervix cancer can change treatment means newly diagnosed women in this province may also receive PET imaging.

17 Sep 2018

Cancer to kill nearly 10 million this year says WHO report

According to a report released by the World Health Organization’s cancer research agency this week, 9.6 million people would lose their lives to cancer this year. This translates as one in eight of all deaths and one in eleven of all deaths among men and women respectively says the agency.

13 Sep 2018

Study provides complete picture of HPV virus-head and neck cancer connections

Human papillomavirus is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils.

12 Sep 2018

New method of cervical cancer screening eliminates Pap test

The United States Preventive Services Task Force has released new recommendations on screening for cervical cancer.

22 Aug 2018

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.

22 Aug 2018

Screening for HPV could replace routine Pap smears

According to health advisors from the U.S. Preventive Services Task Force, Pap smears may not be the only way to check for cervical cancer risk among women.

22 Aug 2018

Comprehensive analysis informs new recommendation for national cervical cancer screening

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

21 Aug 2018

Infection rates of high risk oral HPV in England found to be lower than expected

Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

20 Aug 2018

Discovery may help broaden the scope of defenses against HPV

Yale Cancer Center scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus infects cells.

16 Aug 2018

Cervical Cancer News and Research

Further Reading

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Podcast: KHN’s ‘What the Health?’ Some things old, some things new

Australia will soon become the first country to eradicate cervical cancer

Presence of high-risk HPV in cervical cancer diagnosis linked to improved prognosis

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

‘Contraception deserts’ likely to widen under new Trump administration policy

New combination therapy shows potential in treating incurable HPV-related cancers

HPV vaccination offers best protection against cervical and genital cancers

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

NUS researchers develop new device for quick and accurate screening of diseases

Adding PET scans to CT imaging can change treatment for women with cervical cancer

Cancer to kill nearly 10 million this year says WHO report

Study provides complete picture of HPV virus-head and neck cancer connections

New method of cervical cancer screening eliminates Pap test

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Screening for HPV could replace routine Pap smears

Comprehensive analysis informs new recommendation for national cervical cancer screening

Infection rates of high risk oral HPV in England found to be lower than expected

Discovery may help broaden the scope of defenses against HPV

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News